Fosfenytoin
Fosfenytoin
Klass : C
Visa all info
Skriv ut
Kontakta oss
Ahn JE, Cloyd JC, Brundage RC, Marino SE, Conway JM, Ramsay RE et al. Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy. Neurology. 2008;71:38-43.
Cerebyx (fosphenytoin). DailyMed [www]. US National Library of Medicine. [updated 2019-07-26, cited 2019-10-14].
Pro-Epanutin (fosfenytoin). Summary of Products Characteristics. Swedish Medical Products Agency [updated 2019-07-08, cited 2019-10-14].
Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol. 2003;2:347-56.
Concise (INSIKT). Kalmar: eHälsomyndigheten. 2018 [cited 2019-03-14.]
- Ahn JE, Cloyd JC, Brundage RC, Marino SE, Conway JM, Ramsay RE et al. Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy. Neurology. 2008;71:38-43.
- Cerebyx (fosphenytoin). DailyMed [www]. US National Library of Medicine. [updated 2019-07-26, cited 2019-10-14].
- Pro-Epanutin (fosfenytoin). Summary of Products Characteristics. Swedish Medical Products Agency [updated 2019-07-08, cited 2019-10-14].
- Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol. 2003;2:347-56.
- Concise (INSIKT). Kalmar: eHälsomyndigheten. 2018 [cited 2019-03-14.]